about
Tumor necrosis factor-alpha induces Bax-Bak interaction and apoptosis, which is inhibited by adenovirus E1B 19KHigh-throughput sequencing of microRNAs in adenovirus type 3 infected human laryngeal epithelial cellsUnique sequence features of the Human adenovirus 31 complete genomic sequence are conserved in clinical isolatesTumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death proteinCrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses.Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins.Human cytomegalovirus protein US2 interferes with the expression of human HFE, a nonclassical class I major histocompatibility complex molecule that regulates iron homeostasis.E1B 19K blocks Bax oligomerization and tumor necrosis factor alpha-mediated apoptosis.BMP-functionalised coatings to promote osteogenesis for orthopaedic implantsTNF-alpha -dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection.Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disordersPulmonary immunity to viral infection: adenovirus infection of lung dendritic cells renders T cells nonresponsive to interleukin-2Adenovirus RIDbeta subunit contains a tyrosine residue that is critical for RID-mediated receptor internalization and inhibition of Fas- and TRAIL-induced apoptosisUnabated adenovirus replication following activation of the cGAS/STING-dependent antiviral response in human cells.Inhibition of chemokine expression by adenovirus early region three (E3) genes.Adenovirus species C is associated with chronic suppurative lung diseases in childrenCytokine signalling and disease.The human papillomavirus 16 E6 protein can either protect or further sensitize cells to TNF: effect of doseMutations within the ADP (E3-11.6K) protein alter processing and localization of ADP and the kinetics of cell lysis of adenovirus-infected cells.Inducible nitric oxide synthase expression inhibition by adenovirus E1A.Functions and mechanisms of action of the adenovirus E3 proteins.Gene therapy approaches for bone regeneration.Oncolytic viral therapies.Warts and all: human papillomavirus in primary immunodeficiencies.Distinct domains in the adenovirus E3 RIDalpha protein are required for degradation of Fas and the epidermal growth factor receptor.Molecular evolution of human adenoviruses.Adenoviruses in immunocompromised hostsTrue grit: programmed necrosis in antiviral host defense, inflammation, and immunogenicity.Innate immunity to adenovirus.Bioactive electrospun scaffolds delivering growth factors and genes for tissue engineering applications.Human adenovirus: Viral pathogen with increasing importance.Systematic deletion of the adenovirus-associated RNAI terminal stem reveals a surprisingly active RNA inhibitor of double-stranded RNA-activated protein kinase.BNip3 is a mediator of TNF-induced necrotic cell death.Characterization of E3/49K, a novel, highly glycosylated E3 protein of the epidemic keratoconjunctivitis-causing adenovirus type 19a.Murine cytomegalovirus infection inhibits tumor necrosis factor alpha responses in primary macrophages.Adenovirus virus-associated RNAII-derived small RNAs are efficiently incorporated into the rna-induced silencing complex and associate with polyribosomes.Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients.Specific inhibition of interferon signal transduction pathways by adenoviral infection.[Adenoviral keratoconjunctivitis].Analysis of adenovirus VA RNAI structure and stability using compensatory base pair modifications.
P2860
Q24291723-F0E54B47-8259-4BF1-A6F5-4CF7F6844B2DQ28750518-D1266752-0F0B-4BBE-A9FD-500392ABB403Q30917597-EA80E809-E04D-427D-8867-7B25C9AE1042Q33807026-65F02BC9-6AA4-4A1F-B113-F59A1F5195B6Q33834737-366F9E2E-4CAA-475A-AD97-1C55C997D65CQ33844897-01BCB1DD-D8D2-44DC-963C-B4D10EBF0391Q33848523-BF01835A-D66E-4D19-AC0D-E1B9042B0D5FQ33852843-C45E8243-BFA6-41DB-AB4C-10D83EF4C798Q33907703-D2B71135-96D9-48B3-8D97-8CACC61A27E7Q33947075-CA66814D-2899-4120-BE85-E8F69955A00DQ33985663-838FB9D5-95A4-4D30-B0A5-3A711965B932Q34353313-C7637034-A391-4148-8145-1E9E0E08F7FAQ34356569-59BA330A-EFCE-415B-BAD6-8E2588619869Q34594959-6B8ED1CE-948D-4ACA-8958-8558B2F41558Q35000763-57890CB7-7803-4501-A147-DC013A4FECC1Q35008379-B4D5241F-55C6-4F7B-A075-34ECC8B72A00Q35050409-BBCD1221-8E2F-49C5-AB98-99DA75C9F198Q35098707-41D8BE33-A740-4ACC-87FE-56B3A4B326B1Q35105144-725BED60-899D-4E9F-86B7-D100A2663BE5Q35146799-09F15199-8E91-42D4-813F-791784697992Q35613800-E5DEADA2-CEC9-4DC2-8E07-63205586755EQ35639622-F407A3AD-F285-4DD2-812A-56A2F00656BBQ35852258-2462A63C-531E-4230-ABF3-D97E36D4B873Q36455030-9EE3DD31-E7BD-4632-8591-EF09AFFE3C15Q36541174-F0C7BE72-B7D5-4ABE-B7DE-6A7C1CCC0F01Q36828960-F3DB61A9-F09B-4FD2-9402-F0BF4AB59F23Q37293675-6896F5F1-9BDF-4030-A137-10BF6349B919Q37603408-CCCA6DB3-44D8-4A64-8BC3-92405B14B0A5Q37718852-9672CA98-1263-42F1-A427-4CB031DC6C5EQ37810815-F2DF9351-3F0A-417E-A63D-A5D8FE2C8ED3Q38200093-6FBAF924-FEF7-41E6-9738-FE094CFDF9DCQ39143542-EB811D29-B588-4BC0-ADD8-C8B14F5E9965Q39641646-EA43A85E-F330-47ED-B315-086AA3F835E2Q39686069-6F3D015B-A58A-4332-BA81-8BECC1CECC71Q39996413-A5639B48-C762-46D8-A570-DFB517E2CB34Q40102750-D63765EA-4146-4D11-9752-402CB05A7442Q40560199-E8571179-A9AC-48E7-A8EF-A47B563AE899Q40773522-3F0D2002-CA59-4CA1-8C84-671C37EF10F3Q41258241-34DD157B-10C2-42C4-9A97-5BEA22C60BE8Q41873319-0F3C18A2-BF79-421C-ABFA-05DFE3D04508
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Immune evasion by adenoviruses.
@ast
Immune evasion by adenoviruses.
@en
type
label
Immune evasion by adenoviruses.
@ast
Immune evasion by adenoviruses.
@en
prefLabel
Immune evasion by adenoviruses.
@ast
Immune evasion by adenoviruses.
@en
P2860
P1476
Immune evasion by adenoviruses.
@en
P2093
P2860
P304
P356
10.1111/J.1600-065X.1999.TB01287.X
P577
1999-04-01T00:00:00Z